Project Grant K99DC021983
Award Date
6/1/25
Completion Date
5/31/27
Dollars Obligated
$110K
Federal Grant Program
93.173
Assistance Type
Project Grant
Place of Performance
Madison, WI 53715, USA
Similar Awards
This $118,763 Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), supports a research project to assess human papillomavirus type 16 (HPV16) infections in oral epithelia. The goal is to characterize HPV16's lifecycle and transformative potential in different tonsillar epithelial subtypes, as well as investigate the role of the host transcription factor PPARA in regulating viral...
This Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) provides funding for research focused on understanding the biological mechanisms underlying juvenile-onset recurrent respiratory papillomatosis (JORRP), a rare and serious condition where low-risk HPV viruses cause recurring papillomas in the respiratory tract. The $446,728 award to Children's Hospital Medical Center in Cincinnati, Ohio will support a 5-year research project to investigate how the...
This Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), will fund research to investigate the inflammatory mechanisms and immune responses underlying the development of laryngeal glottic stenosis following acute laryngeal injury from intubation and mechanical ventilation. The $142,074 award to the University of Wisconsin-Madison will support a 5-year study...
This $533,707 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to elucidate how the human papillomavirus (HPV) E7 oncoprotein disrupts the balance between proliferation and differentiation in epithelial cells, enabling persistent HPV infection and contributing to carcinogenesis. The key objectives are to 1) determine the mechanism by which HPV E7-mediated...
The National Institute on Deafness and Other Communication Disorders (NIDCD) awarded a $633,694 Project Grant under CFDA 93.173 (Research Related to Deafness and Communication Disorders) to North Carolina State University (NC State) to develop a non-invasive therapy using vocal fold lamina propria extract (VFLPX) to treat vocal fold scarring and laryngotracheal injuries. The project aims to: (1) investigate the anti-fibrotic and anti-microbial properties of VFLPX through advanced proteomic...
The National Institute of Dental and Craniofacial Research (NIDCR) has awarded a $515,812 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to The Johns Hopkins University. The award will fund a prospective observational cohort study to examine the progression to HPV-related oropharynx cancer (HPV-OPC) in people living with and without HIV. The study aims to: 1) study progression to HPV-OPC and how it differs in those with and without HIV; 2) characterize the...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. The $2,764,816 grant, awarded on August 1, 2024, will fund research to elucidate the interactions between HPV E6 oncoprotein levels, mitochondrial function, and progression of HPV-positive oropharyngeal squamous...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $164,000.00 to evaluate the feasibility and acceptability of using mail-delivered sample collection kits to test for oral HPV DNA infection among a diverse population of people living with HIV (PLWH). The study aims to assess the agreement between at-home self-collected samples and clinic-collected samples for detecting...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $2,942,347 to the Regents of the University of Michigan to conduct research aimed at improving understanding of the role of human papillomavirus (HPV) integration structures in head and neck squamous cell carcinoma (HNSCC) molecular heterogeneity. The research seeks to determine the accuracy of using local sequence...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $204,688 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to The Johns Hopkins University from May 1, 2025 to April 30, 2027. The grant aims to develop a novel cancer immunotherapy approach for HPV-associated head and neck cancers. Key components include: Evaluating the ability of Salmonella-derived outer membrane vesicles coated with the HPV E7 antigen (SOMV-9RE7) to induce tumor...